Bayesian Phylogeographic Analysis Incorporating Predictors and Individual Travel Histories in BEAST.


Journal

Current protocols
ISSN: 2691-1299
Titre abrégé: Curr Protoc
Pays: United States
ID NLM: 101773894

Informations de publication

Date de publication:
Apr 2021
Historique:
entrez: 9 4 2021
pubmed: 10 4 2021
medline: 22 4 2021
Statut: ppublish

Résumé

Advances in sequencing technologies have tremendously reduced the time and costs associated with sequence generation, making genomic data an important asset for routine public health practices. Within this context, phylogenetic and phylogeographic inference has become a popular method to study disease transmission. In a Bayesian context, these approaches have the benefit of accommodating phylogenetic uncertainty, and popular implementations provide the possibility to parameterize the transition rates between locations as a function of epidemiological and ecological data to reconstruct spatial spread while simultaneously identifying the main factors impacting the spatial spread dynamics. Recent developments enable researchers to make use of travel history data of infected individuals in the reconstruction of pathogen spread, offering increased inference accuracy and mitigating sampling bias. Here, we describe a detailed workflow to reconstruct the spatial spread of a pathogen through Bayesian phylogeographic analysis in discrete space using these novel approaches, implemented in BEAST. The individual protocols focus on how to incorporate molecular data, covariates of spread, and individual travel history data into the analysis. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Creating a SARS-CoV-2 MSA using sequences from GISAID Basic Protocol 2: Setting up a discrete trait phylogeographic reconstruction in BEAUti Basic Protocol 3: Phylogeographic reconstruction incorporating travel history information Basic Protocol 4: Visualizing ancestral spatial trajectories for specific taxa.

Identifiants

pubmed: 33836121
doi: 10.1002/cpz1.98
pmc: PMC8672455
mid: NIHMS1758158
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e98

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI135995
Pays : United States
Organisme : European Research Council
ID : 725422-ReservoirDOCS
Pays : International
Organisme : NIH HHS
ID : AI135995
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI153044
Pays : United States
Organisme : European Research Council
ID : 874850
Pays : International
Organisme : Wellcome Trust
ID : 206298/Z/17/Z
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Mol Biol Evol. 2012 Aug;29(8):1969-73
pubmed: 22367748
BMC Evol Biol. 2007 Nov 08;7:214
pubmed: 17996036
Virus Evol. 2019 Feb 28;5(1):vey043
pubmed: 30838129
Bioinformatics. 2018 Nov 15;34(22):3843-3848
pubmed: 29790921
Mol Biol Evol. 2010 Aug;27(8):1877-85
pubmed: 20203288
Mol Biol Evol. 2019 Jul 31;:
pubmed: 31364710
PLoS Pathog. 2014 Feb 20;10(2):e1003932
pubmed: 24586153
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
PLoS Comput Biol. 2009 Sep;5(9):e1000520
pubmed: 19779555
Trends Ecol Evol. 2015 Jun;30(6):306-13
pubmed: 25887947
Mol Biol Evol. 2020 Jun 1;37(6):1832-1842
pubmed: 32101295
PLoS Genet. 2015 Aug 12;11(8):e1005421
pubmed: 26267488
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Bioinformatics. 2014 Nov 15;30(22):3276-8
pubmed: 25095880
Mol Biol Evol. 2020 Nov 1;37(11):3363-3379
pubmed: 32895707
Mol Biol Evol. 2009 Jan;26(1):143-53
pubmed: 18922760
Nat Commun. 2020 Oct 9;11(1):5110
pubmed: 33037213
Syst Biol. 2019 Nov 1;68(6):1052-1061
pubmed: 31034053

Auteurs

Samuel L Hong (SL)

Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Laboratory of Clinical and Evolutionary Virology, Leuven, Belgium.

Philippe Lemey (P)

Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Laboratory of Clinical and Evolutionary Virology, Leuven, Belgium.

Marc A Suchard (MA)

Department of Biomathematics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California.
Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Guy Baele (G)

Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Laboratory of Clinical and Evolutionary Virology, Leuven, Belgium.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH